Cargando…

A New Anti-oestrogenic Agent in Late Breast Cancer: An Early Clinical Appraisal of ICI46474

An introductory clinical trial of the anti-oestrogenic agent IC146474 in late or recurrent carcinoma of the breast is described. Forty-six patients have been treated, of whom 10 have shown a good response. This is of the same order as that seen with oestrogens and androgens. The particular advantage...

Descripción completa

Detalles Bibliográficos
Autores principales: Cole, M. P., Jones, C. T. A., Todd, I. D. H.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1971
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2008453/
https://www.ncbi.nlm.nih.gov/pubmed/5115829